Dr. Varadarajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1266 Hartland Dr
Troy, MI 48083- Is this information wrong?
Education & Training
- Wayne State University School of MedicineClass of 2019
Publications & Presentations
PubMed
- Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Bura...> ;Cancer Discovery. 2024 May 1
- Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Den...> ;Molecular Cancer Therapeutics. 2024 Apr 20
- 1 citationsConvergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.DiPeri, T., Zhao, M., Evans, K., Varadarajan, K., Moss, T., Scott, S., Kahle, M., Byrnes, C., Chen, H., Lee, S., Halim, A., Hirai, H., Wacheck, V., Kwong, L., Rodon, J...> ;Journal of Hepatology. 2024 Feb 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: